Intrathecal pumps are
widely used in the treatment of patients suffering from chronic pain without
any/minimal side-effects. Economic factors such as, U.S. health insurance policies
have boosted the demand of the intrathecal pumps market. Moreover, with advancing
technology of the intrathecal pumps, the feasibility and flexibility of these
devices have also grown with the current diagnostic methods, which in-turn is
driving the intrathecal pumps market. Drugs such as Baclofen and
Trihexy-phenidyl, which are used for the treatment of neuro-degeneration with
brain iron accumulation and dystonia are not available in oral form, and hence,
the demand of technically advanced intrathecal pumps with ability to perform
multiple medications via single infusion pump has increased in recent years.
Explore Report Sample at: https://www.psmarketresearch.com/market-analysis/intrathecal-pumps-market/report-sample
Intrathecal pumps are used extensively
for the injecting specific drugs to cancer patients. According to a report published
by the International Agency for Research on Cancer (IARC of WHO), the number of
cancer patients has been considerably increased. About 14.1 million patients
were estimated to suffer from cancer in 2012. Also, the cancer mortality rate
was estimated to be about 8.2 million in the year 2012. With increasing
prevalence of cancer, the intrathecal pumps market is expected to escalate in
future.
Based on the various drug
types, the global intrathecal pumps market can be broadly categorized as Baclofen,
Hydromorphone, Morphine, Clonidine, Midazolam, Bupivacaine and others. Based on
the different application of intrathecal pumps, the global intrathecal pumps
market can be broadly classified into spasticity and pain management. Pain
management occupied the maximum intrathecal pumps market’s share in 2014.
Explore more about “Global Intrathecal Pumps Market” at: https://www.psmarketresearch.com/market-analysis/intrathecal-pumps-market
Recently Flowonix Medical
Inc., has launched a ‘Prometra’ intrathecal pump, featuring accurate drug
delivery mechanism, dual-gated valve drug delivery and increased device
longevity. Rising merger and accusation (M&A) activity and market
consolidation in the global intrathecal pump market is expected to drive the intrathecal
pump market during the forecast period.
Some of the major players
operating in the global intrathecal pumps market include- Arrow International
Medallion Therapeutics Inc., Codman & Shurtleff, Inc., Medtronic, Inc., and
Flowonix, Inc., Tricumed GmbH among
others.
No comments:
Post a Comment